{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/MTVA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T13:11:33.634Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6722,"canonical_name":"MetaVia Inc.","cik":"0001638287","uei":null,"lei":null,"duns":null,"ticker":"MTVA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":19},"count":19,"timeline":[{"ts":"2026-07-09","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-07-09","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-082116","accession_number":"0001104659-26-082116","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-07-02","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-080316","accession_number":"0001104659-26-080316","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"424B5","title":"424B5 — MetaVia Inc. — 2026-07-02","url_slug":"/sec/cik-0001638287/424b5/0001104659-26-080305","accession_number":"0001104659-26-080305","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-06-08","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-071211","accession_number":"0001104659-26-071211","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-06-08","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-071358","accession_number":"0001104659-26-071358","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Glickman Mark A — 2026-06-08","url_slug":"/sec/cik-0001441461/4/0001104659-26-071469","accession_number":"0001104659-26-071469","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — MetaVia Inc. — 2026-06-08","url_slug":"/sec/cik-0001638287/4/0001104659-26-071473","accession_number":"0001104659-26-071473","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"S-8","title":"S-8 — MetaVia Inc. — 2026-06-08","url_slug":"/sec/cik-0001638287/s-8/0001104659-26-071406","accession_number":"0001104659-26-071406","importance":30},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"STRICKLAND D GORDON","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"KOVEN ANDREW I","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"GROVES JASON L","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"Tursi James Patrick","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"Salsbury Michael","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.a","reporter":"Glickman Mark A","title":"","shares":17186,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-05-18","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-063059","accession_number":"0001104659-26-063059","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — MetaVia Inc. — 2026-05-14","url_slug":"/sec/cik-0001638287/10-q/0001104659-26-061166","accession_number":"0001104659-26-061166","importance":45},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — MetaVia Inc. — 2026-05-14","url_slug":"/sec/cik-0001638287/8-k/0001104659-26-061148","accession_number":"0001104659-26-061148","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — MetaVia Inc. — 2026-04-27","url_slug":"/sec/cik-0001638287/def-14a/0001140361-26-016802","accession_number":"0001140361-26-016802","importance":40},{"ts":"2026-04-27","kind":"sec.filing","form_type":"ARS","title":"ARS — MetaVia Inc. — 2026-04-27","url_slug":"/sec/cik-0001638287/ars/0001140361-26-016808","accession_number":"0001140361-26-016808","importance":30}]}